Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Multiple Sclerosis

  Free Subscription


22.04.2024

2 BMC Neurol
1 Brain
1 Clin Exp Immunol
1 J Neuroimmunol
3 J Neurol
1 J Neurol Neurosurg Psychiatry
6 Mult Scler
1 Nat Med
2 PLoS One
1 Rev Neurol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. MOTL RW, Bombardier CH, Duffecy J, Hibner B, et al
    Study protocol: exercise training for treating major depressive disorder in multiple sclerosis.
    BMC Neurol. 2024;24:131.
    PubMed         Abstract available

  2. HOLZ A, Obi N, Ahrens W, Berger K, et al
    Childhood and adolescence factors and multiple sclerosis: results from the German National Cohort (NAKO).
    BMC Neurol. 2024;24:123.
    PubMed         Abstract available


    Brain

  3. HUANG J, Tengvall K, Bomfim Lima I, Hedstrom AK, et al
    Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Brain. 2024 Apr 17:awae110. doi: 10.1093.
    PubMed         Abstract available


    Clin Exp Immunol

  4. MARTIN-GUTIERREZ L, Waddington KE, Maggio A, Coelewij L, et al
    Dysregulated Lipid Metabolism Networks Modulate T-cell Function in People with Relapsing Remitting Multiple Sclerosis.
    Clin Exp Immunol. 2024 Apr 16:uxae032. doi: 10.1093.
    PubMed         Abstract available


    J Neuroimmunol

  5. MUNZ C
    Altered EBV specific immune control in multiple sclerosis.
    J Neuroimmunol. 2024;390:578343.
    PubMed         Abstract available


    J Neurol

  6. SPIEZIA AL, Scalia G, Petracca M, Caliendo D, et al
    Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications.
    J Neurol. 2024 Apr 17. doi: 10.1007/s00415-024-12362.
    PubMed         Abstract available

  7. HIRT J, Dembowska K, Woelfle T, Axfors C, et al
    Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis.
    J Neurol. 2024 Apr 16. doi: 10.1007/s00415-024-12366.
    PubMed         Abstract available

  8. SINGER BA, Feng J, Chiong-Rivero H
    Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.
    J Neurol. 2024 Apr 14. doi: 10.1007/s00415-024-12305.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  9. ABDEL-MANNAN O, Champsas D, Tur C, Lee V, et al
    Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course.
    J Neurol Neurosurg Psychiatry. 2024;95:426-433.
    PubMed         Abstract available


    Mult Scler

  10. OZTURK B, Taskiran E, Demir S, Tuncer MA, et al
    Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study.
    Mult Scler. 2024 Apr 14:13524585241245318. doi: 10.1177/13524585241245318.
    PubMed         Abstract available

  11. TOOSY AT, Barkhof F
    Multiple sclerosis can be diagnosed solely with dissemination in space: Yes.
    Mult Scler. 2024 Apr 14:13524585241245313. doi: 10.1177/13524585241245313.
    PubMed        

  12. MCGINLEY MP, Cohen JA
    Multiple sclerosis can be diagnosed solely with dissemination in space: Commentary.
    Mult Scler. 2024 Apr 14:13524585241245319. doi: 10.1177/13524585241245319.
    PubMed        

  13. HEMOND CC, Solomon AJ
    Multiple sclerosis can be diagnosed solely with dissemination in space: No.
    Mult Scler. 2024 Apr 14:13524585241245297. doi: 10.1177/13524585241245297.
    PubMed        

  14. CHITNIS T, Banwell B, Kappos L, Arnold DL, et al
    Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.
    Mult Scler. 2024 Apr 15:13524585241242050. doi: 10.1177/13524585241242050.
    PubMed         Abstract available

  15. OKUDA DT, Lebrun-Frenay C
    Radiologically isolated syndrome in the spectrum of multiple sclerosis.
    Mult Scler. 2024 Apr 15:13524585241245306. doi: 10.1177/13524585241245306.
    PubMed         Abstract available


    Nat Med

  16. ZAMECNIK CR, Sowa GM, Abdelhak A, Dandekar R, et al
    An autoantibody signature predictive for multiple sclerosis.
    Nat Med. 2024 Apr 19. doi: 10.1038/s41591-024-02938.
    PubMed         Abstract available


    PLoS One

  17. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    PubMed         Abstract available

  18. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    PubMed         Abstract available


    Rev Neurol

  19. RODRIGUEZ-MENENDEZ S, Martinez-Piedrola RM, Menendez-Gonzalez M, Perez-de-Heredia-Torres M, et al
    Influence of manipulative skills on quality of life and activities of daily living in multiple sclerosis.
    Rev Neurol. 2024;78:213-218.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.